Biogened S.A. (WSE: BGD)

Poland flag Poland · Delayed Price · Currency is PLN
28.80
+3.40 (13.39%)
At close: Jan 17, 2025
46.19%
Market Cap 63.86M
Revenue (ttm) 107.22M
Net Income (ttm) 4.87M
Shares Out 2.46M
EPS (ttm) 1.98
PE Ratio 13.11
Forward PE n/a
Dividend 0.50 (1.92%)
Ex-Dividend Date Sep 12, 2024
Volume 148
Average Volume 81
Open 25.60
Previous Close 25.40
Day's Range 25.60 - 28.80
52-Week Range 16.20 - 32.60
Beta 0.80
RSI 79.82
Earnings Date Feb 14, 2025

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 209
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2023, Biogened's revenue was 95.56 million, an increase of 20.02% compared to the previous year's 79.62 million. Earnings were 5.10 million, an increase of 50.74%.

Financial Statements

News

There is no news available yet.